| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/18/2006 | EP1711187A2 Reducing arthritis and lameness in subjects by growth hormone releasing hormone (ghrh) supplementation |
| 10/18/2006 | EP1711172A2 Compositions and methods for combined therapy of disease |
| 10/18/2006 | EP1711165A2 Membrane scaffold proteins |
| 10/18/2006 | EP1711052A1 Mouse model for psoriasis and psoriatic arthritis |
| 10/18/2006 | EP1711051A1 Transgenic animals for assessing drug metabolism and toxicity in man |
| 10/18/2006 | EP1578768A4 Novel peptide dimers as agonists of the erythropoietin (epo) receptor, and associated methods of synthesis and use |
| 10/18/2006 | EP1543329A4 Cell-based fluorescence resonance energy transfer (fret) assays for clostridial toxins |
| 10/18/2006 | EP1448595B1 Antimicrobial polypeptides from pseudoplectania nigrella |
| 10/18/2006 | EP1404872B1 Method of selecting a dna sequence with transcription modulating activity using a vector comprising an element with a gene transcription repressing activity |
| 10/18/2006 | EP1389236B1 Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof |
| 10/18/2006 | EP1358332B1 A serpin in bifidobacteria |
| 10/18/2006 | EP1339849B1 PLANT POLYNUCLEOTIDES ENCODING NOVEL Na+ /H+ ANTIPORTERS |
| 10/18/2006 | EP1337636B1 Soluble zcytor 11 cytokine receptors |
| 10/18/2006 | EP1280821B1 Dna molecules encoding ligand gated ion channels from dermacentor variabilis |
| 10/18/2006 | EP1212352B1 Peptide analogs as selective inhibitors of thrombin activation of protease activated receptor 1 |
| 10/18/2006 | EP1210411B1 Compositions and methods for improved cell culture |
| 10/18/2006 | EP1208196B1 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof |
| 10/18/2006 | EP1200588B1 Single-chain polypeptides comprising troponin i n-terminal fragments and troponin c |
| 10/18/2006 | EP1198577B1 Mutant gene of the gras family and plants with reduced development containing said mutant gene |
| 10/18/2006 | EP1194554B1 Delivery of trefoil peptides |
| 10/18/2006 | EP1171601B1 Nucleic acids encoding a mutt domain-containing polypeptide |
| 10/18/2006 | EP1165778B1 Uses of casb618 polynucleotides and polypeptides |
| 10/18/2006 | EP1155119B1 Bhv-1 gene-deleted virus vaccine |
| 10/18/2006 | EP1144666B1 Replication deficient baculovirus expression system |
| 10/18/2006 | EP1144611B1 Method for recombinant protein production in mammalian cells comprising co-expression with fetuin |
| 10/18/2006 | EP1141286B1 Cytokine receptor chain |
| 10/18/2006 | EP1131434B1 Apoptosis-inducing factor |
| 10/18/2006 | EP1127126B1 G-protein coupled receptors, homologous to ebv-induced gpcr 2 (ebi-2). methods to seek for ligands thereof |
| 10/18/2006 | EP1119611B1 Composition for use in chemonucleolysis |
| 10/18/2006 | EP1105731B1 Profiling and cataloging expressed protein tags |
| 10/18/2006 | EP1104479B1 Method for recovering proteins from the interstitial fluid of plant tissues |
| 10/18/2006 | EP1078050B1 A vector for gene trap, and a method for gene trapping by using the vector |
| 10/18/2006 | EP1071710B1 Genomic sequence of the 5-lipoxygenase-activating protein (flap), polymorphic markers thereof and methods for detection of asthma |
| 10/18/2006 | EP1042468B1 Low-voltage activated calcium channel compositions and methods |
| 10/18/2006 | EP1019500B1 Ifn receptor 1 binding proteins, dna encoding them, and methods of modulating cellular response to interferons |
| 10/18/2006 | EP1007082B1 Modified tumor necrosis factor |
| 10/18/2006 | EP1004667B1 Cell cycle-regulating proteins |
| 10/18/2006 | EP0991661B1 Chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof |
| 10/18/2006 | EP0979239B1 Prevention and treatment of hepatocellular cancer |
| 10/18/2006 | EP0969862B1 Synthetic hiv gag genes |
| 10/18/2006 | EP0948511B1 Chemical synthesis of nucleosides analogs and their incorporation into polynucleotides |
| 10/18/2006 | EP0944649B1 METHYLATED, SmD HOMOLOGOUS PEPTIDES, REACTIVE WITH THE ANTIBODIES FROM SERA OF LIVING BEINGS AFFECTED WITH SYSTEMIC LUPUS ERYTHEMATOSUS |
| 10/18/2006 | EP0939828B1 Herpesvirus saimiri as viral vector |
| 10/18/2006 | EP0877756B1 Anti-microbial protein |
| 10/18/2006 | EP0821729B1 Structure-based designed herbicide resistant products |
| 10/18/2006 | EP0797664B1 Use of a human interleukin-11 receptor |
| 10/18/2006 | EP0656788B1 Hla binding peptides and their uses |
| 10/18/2006 | CN1849400A Polynucleotides and polypeptides of the erythropoietin gene |
| 10/18/2006 | CN1849397A Insecticidal proteins secreted from bacillus thuringiensis and uses therefor |
| 10/18/2006 | CN1849395A HLA-a24 binding cancer antigen peptide derived from ribin |
| 10/18/2006 | CN1849337A Compositions and methods for treating cancer using IGSF9 and LIV-1 |
| 10/18/2006 | CN1849336A Chimeric gabab receptor |
| 10/18/2006 | CN1849335A Methods of dissociating nongenotropic from genotropic activity of steroid receptors |
| 10/18/2006 | CN1849334A Lawsonia intracellularis subunit vaccine |
| 10/18/2006 | CN1849329A CNGH0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses |
| 10/18/2006 | CN1849142A 2'-branched nucleosides and flaviviridae mutation |
| 10/18/2006 | CN1849141A Spacer moiety for poly(ethylene glycol)-modified peptide- based compounds |
| 10/18/2006 | CN1849134A Functional influenza virus-like particles(VLPs) |
| 10/18/2006 | CN1847398A Recombinant dust mite class-II allergen |
| 10/18/2006 | CN1847396A Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 10/18/2006 | CN1847395A Lefteye flounder FOLLISTATIN gene sequence and its coded protein sequence |
| 10/18/2006 | CN1847389A L-lysine producing coryneform bacteria and methods for the production of L-lysine |
| 10/18/2006 | CN1847265A Human chorionic gonadotropic hormone beta strand carboxyl terminal 37 peptide polymer and its use |
| 10/18/2006 | CN1847264A Insulin release promoter factor of rana grahami and its medicinal application |
| 10/18/2006 | CN1847263A Protein from snake venom for preventing and treating pyemia |
| 10/18/2006 | CN1847262A One kind of protein and its use |
| 10/18/2006 | CN1847261A Cyclic peptides as g-protein-coupled receptor antagonists |
| 10/18/2006 | CN1847259A Preparation of a therapeutic composition |
| 10/18/2006 | CN1846718A Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
| 10/18/2006 | CN1280415C Wheat disease-resistant gene Lr-L1 and its use |
| 10/18/2006 | CN1280309C Erythropoietin with high specific activity |
| 10/18/2006 | CN1280308C Production of polysaccharide peptide |
| 10/18/2006 | CN1280307C Cytotoxin T lymphocyte |
| 10/18/2006 | CN1280306C Method for purifying Sa antigen |
| 10/18/2006 | CN1279978C Purification method of dermatonecrotoxin and anatoxin produced by Bordetella |
| 10/18/2006 | CN1279977C Peptide-based fluorescence polarization assay for detection of antibodies to mycobacterium bovis |
| 10/18/2006 | CN1279971C Novel method for down-regulation of amyloid |
| 10/17/2006 | USRE39355 Fusion protein with amino acid sequence of mature human insulin-like growth factor; synthesized in recombinant cell culture by host cells transformed with expression vectors; genetic engineering |
| 10/17/2006 | USRE39350 RNA binding protein and binding site useful for expression of recombinant molecules |
| 10/17/2006 | US7122727 Nucleic acid molecules from wheat encoding an R1-protein, and transgenic plant cells and plants comprising the nucleic acid molecules |
| 10/17/2006 | US7122726 Inbred maize line NP2460 |
| 10/17/2006 | US7122723 Plant recombination proteins |
| 10/17/2006 | US7122716 Enhanced plant cell transformation by addition of host genes involved in T-DNA integration |
| 10/17/2006 | US7122658 Seed-preferred regulatory elements and uses thereof |
| 10/17/2006 | US7122657 UDP-glucose aglycon-glucosytransferase |
| 10/17/2006 | US7122656 MyD88S allows activation of JNK and AP-1, whereas the NF- kappa B pathway is completely blocked; used to obtain immunosuppression (e.g., in the case of transplantation); modulation of the expression of MyD88S can regulate the cellular responses to LPS and other immunological stimuli |
| 10/17/2006 | US7122655 Compositions involving M-RIP, and related methods for screening for anti-hypertensive agents, and uses thereof |
| 10/17/2006 | US7122654 Hybrid; adjust vascular system permeability |
| 10/17/2006 | US7122652 Isolated polynucleotide encoding a variant human pregnane X receptor (hPXR) polypeptide or fragment; detection and genotyping of hPXR alleles in humans, homozygous as well as heterozygous, alleles of the hPXR gene |
| 10/17/2006 | US7122651 Nucleic acid molecules encoding opioid growth factor receptors |
| 10/17/2006 | US7122650 Comprises nucleotide sequences coding polypeptide which inactivates corticotropin-releasing factor (CRF) for use as to in treatment of anxiety and depression |
| 10/17/2006 | US7122649 Derivatized oligonucleotides having improved uptake and other properties |
| 10/17/2006 | US7122648 Isolated nucleic acids; binding to antibody; diagnosis of muscular disorders |
| 10/17/2006 | US7122644 Methods and compositions for inhibiting neoplastic cell growth |
| 10/17/2006 | US7122641 Methods for purifying protein |
| 10/17/2006 | US7122639 Chemokine alpha-2 antibodies |
| 10/17/2006 | US7122634 With an immunoreactivity-reducing amino acid of alanine, methionine, leucine; substituting for the naturally-occurring amino acid; correcting hemophilia in a patient deficient in factor VIII or having inhibitors to factor VIII |
| 10/17/2006 | US7122633 Natural killer stimulatory factor |
| 10/17/2006 | US7122632 Able to down-regulate IL-20; treating inflammatory diseases, psoriasis and inflammatory lung diseases |
| 10/17/2006 | US7122631 Secreted and transmembrane polypeptides and nucleic acids encoding the same |